Our study currently focuses on the comprehensive exploration about the upstream regulatory mechanisms of KIF15 regarding to its promotion in GBM progression, although MTT assay in Fig. S1 preliminarily indicated that, both Erk/AKT and cell cycle pathway were responsible for the tumor-promoting role of KIF15 as the possible key downstream signaling pathways. Here, AKT1 is linked to neoplasm.